The Workshop Programme 2026

Save the Date – DDI Workshop 2026

The upcoming Workshop will take place from May 31^st to June 2^nd, 2026.

In its 16^th year, the Marbach Workshop brings together international experts to discuss current topics in drug-drug interactions. The 2026 event will update attendees on ­recent scientific advances and clinical applications.

The workshop starts Monday, June 1^st, 2026, with Session I: DDI Implementation from Bench to Bedside. Presentations will cover challenges in applying research to clinical practice, especially for DDIs and pharmacogenomics. Academic and regulatory speakers will address knowledge gaps at drug approval, and industry experts will discuss personalized DDI management strategies.

Following a discussion at 2025 workshop with regard to publication of European Medicines Agency’s (EMA) opinion report on qualifying PBPK platforms for DDI prediction, the 2026 workshop will dedicate a session (Session II) where experts from EMA, UK’s MHRA, Certara, and J&J will reflect on review experience of regulator and software developer, and present stakeholders’ feedback on the first-of-its-kind PBPK qualification report.

On Tuesday, June 2^nd, Session III covers managing complex drug interactions in vulnerable groups, including case studies from the COVID-19 pandemic and strategies for geriatric and underserved patient groups.

Session IV focuses on advancements in in vitro assays for non-CYP induction, discussing UGT induction, PBPK extrapolation, and CYP3A /UGT co-induction in DDI prediction.

Each session during the event will include interactive discussions, and participants may submit abstracts for poster presentations in Session V: Poster Session. The workshop provides an opportunity for exchanging information and networking.

The Workshop Organizers

Uwe Fuhr, MD
Amin Rostami-Hodjegan, PhD, FCP
Ping Zhao, PhD
Isabelle Ragueneau-Majlessi, MD
Dr. Wafaâ Jabrane